Search Results - Tim L Jansen
- Showing 1 - 5 results of 5
-
1
-
2
Real-life results of urate-driven pharmacotherapy with three urate lowering drugs in gout: allopurinol, febuxostat and benzbromarone by Ioana Hotea, Tanja Giesen, Antoaneta Comarniceanu, Monique Efde, Frits van Osch, Matthijs Janssen, Tim L. Jansen
Published in Exploration of Musculoskeletal Diseases (2023-08-01)Get full text
Article -
3
Understanding the patient voice in gout: a quantitative study conducted in Europe by Marc De Meulemeester, Elsa Mateus, Hilda Wieberneit-Tolman, Neil Betteridge, Lucy Ireland, Gudula Petersen, Nina Jeanette Maske, Tim L Jansen, Fernando Perez-Ruiz
Published in BJGP Open (2020-02-01)Get full text
Article -
4
The Toll-Like Receptor 4 (TLR4) Variant rs2149356 and Risk of Gout in European and Polynesian Sample Sets. by Humaira Rasheed, Cushla McKinney, Lisa K Stamp, Nicola Dalbeth, Ruth K Topless, Richard Day, Diluk Kannangara, Kenneth Williams, Malcolm Smith, Matthijs Janssen, Tim L Jansen, Leo A Joosten, Timothy R Radstake, Philip L Riches, Anne-Kathrin Tausche, Frederic Lioté, Leo Lu, Eli A Stahl, Hyon K Choi, Alexander So, Tony R Merriman
Published in PLoS ONE (2016-01-01)Get full text
Article -
5
Multi-biomarker disease activity score as a predictor of disease relapse in patients with rheumatoid arthritis stopping TNF inhibitor treatment. by Marjan Ghiti Moghadam, Femke B G Lamers-Karnebeek, Harald E Vonkeman, Peter M Ten Klooster, Janneke Tekstra, Annemarie M Schilder, Henk Visser, Eric H Sasso, David Chernoff, Willem F Lems, Dirk-Jan van Schaardenburg, Robert Landewe, Hein J Bernelot Moens, Timothy R D J Radstake, Piet L C M van Riel, Mart A F J van de Laar, Tim L Jansen, Dutch National POET Collaboration
Published in PLoS ONE (2018-01-01)Get full text
Article
